-
Peaceful Repeat Vote in Douglas Ward 3 Amid Heightened Security
-
‘They want silence’: how the film NAZA is shaking Israel
-
Belgian Ambassador Marks King’s Day in Athens Amidst Strong Bilateral Trade Ties
-
Dún Laoghaire-Rathdown €335m Budget Faces Mixed Reaction Over Housing and Cost of Living
-
Rediff.com IPO Risks: Gmail Dominance and New Business Ventures
-
BING X: 22,624.66 SNC have disappeared at BingX – how safe are tokens on BingX? Will BingX’s MiCAR licence be suspended?
-
Dubai Police Expand Luxury Patrol Fleet with 525-hp Defender
-
Iran Strikes US Sites in Kuwait Following US Airstrikes on Qeshm Island
-
ESGold Expands Montauban Gold-Silver Property to Approximately 26,787 Hectares Through Strategic Claim Staking
-
Investments & Wealth Institute Expands Advanced Education Offerings for 2027, Announces Next Experience Conference in Nashville
-
Wedgewood Weddings Acquires Swan Lake Overlook, Where Alpacas, Deer, and Mountain Views Join the Guest List
-
DSS Announces Completion of Impact Biomedical Business Combination with Zoar Limited
-
Newsmax Expands Over-the-Air Reach with HC2 Broadcasting Distribution Agreement for Newsmax2
-
Impala and Philanthropy Southwest Launch Southwest Hub, Mapping Philanthropy Across Eight States
-
HTB Activ(TM) Trial Demonstrates Significant Improvement in Cognitive Abilities
-
Nixxy Announces 1-for-20 Reverse Stock Split
-
IGC Pharma Completes Dosing in Phase 2 CALMA Trial of IGC-AD1 for Agitation in Alzheimer's Dementia
-
The IRS Watchdog Just Published Its FY 2027 Challenges List - Clear Start Tax Explains Why Agency Strain Rarely Slows Down Collection Notices
-
Who Does the Best Deep Plane Facelift in Oklahoma?
-
LHH ICEO Research Led by Harvard Business School Professor Maps Four Paths for Work Beyond the C-Suite
-
cbdMD Applauds Introduction of the Bipartisan Hemp Guardrails Act, Calling It a Win for Consumer Safety, American Jobs and Tax Revenue
-
Bell Rose Capital (OTCID:BELR) Makes Major Move Into Streaming Entertainment With Spark TV Partnership And New Billy Carson Series "The Missing Chapter"
-
Tocvan Defines Priority Gold Target Areas at Gran Pilar From Project-Wide Soil Sampling and Geologic Mapping; 225 Soils at or Above 100 ppb Gold
-
NuRAN Wireless Raises First Two Towers in Benin as 4G Rollout Beats Expectations in Cameroon and Ivory Coast
-
Rockhaven Announces Successful Completion of 2026 Klaza Bulk Sample Program
-
Silver Storm to Attend the 121 Mining Investment Conference in London, UK
-
American Resources Corporation Provides Strategic Business and Financial Reporting Update
-
Who Does the Best Deep Plane Facelift in Sarasota?
-
Jumia Reports Third Quarter 2026 Results
-
Ameriwest Advances Its Copper Focused Strategy Through Proposed Sale of Railroad Valley to Pure Energy Minerals
-
1933 Industries Completes LED Lighting Retrofit at Its 68,000 Sq. Ft. Cannabis Cultivation Facility in Las Vegas, Nevada - Ranks #3 in Cannabis Flower Sales
-
AbTherx Licenses Atlas(TM) Platform to Athenova Therapeutics for Next-Generation Targeted Alpha Radiopharmaceutical Discovery
-
DataMeds AI Subsidiary Helomics, Inc. Announces Cancer Target Discovery and Anticancer Peptides Drug Development Partnership With DiaGen AI, Inc.
-
What to Do When Two Households Become One
-
SmartBuyerAI Gives Car Buyers an Itemized Check of Dealer Offers as FTC Steps Up Price Transparency Enforcement
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 18
-
Fulcrum Metals PLC Announces Uranium Readings up to 0.42% U(3)O(8) at Charlot-Neely
-
Leggett Dynamics Wins 2026 Automotive News PACE Pilot Award For Smart Brushless Motor
-
Wyyerd Fiber Brings Arizona's Fastest Internet to the City of Phoenix
-
Digital Infrastructure World 2027 Announces First 85 Speakers as Registrants Represent 80GW of AI Buying Capacity
-
Bill Shelow, LIBRA Insurance Partners President and CEO, Receives NAILBA’s 2026 Douglas Mooers Award for Excellence
-
Oleria Extends Identity Governance to AI Agents, Tracing Every Agent Through the People and Credentials It Acts For
-
UCLA's Scooter Jackson named Week 11 Lott IMPACT Trophy Player of the Week
-
Paris Hilton Guides Loti as Chief Advocacy Officer to Put Digital Identity Protection in Everyone's Hands
-
Ondas and Aston Martin Aramco Formula One Team Launch Multi-Year Partnership Built for "Speed to Decision"
-
Who Does the Best Testosterone Replacement Therapy in Las Vegas?
-
CMP 2026-2027 Nonprofit Leadership Pulse Check
-
Nexteer's HMDD Wins Innovation Awards from PACE Pilot, CES and AutoTech Breakthrough
-
Coa Wealth Launches AI-Powered Software That Functions as a Private Investment Office for Individual Investors and Families
-
More Than Keyboards: Epomaker Brings Its Gaming World to G-STAR 2026
Chronic drug shortages frustrate EU pharmacists, patients
At a drug wholesaler warehouse in Belgium, shelves are emptier than they used to be.
Like other EU nations, Belgium has increasingly experienced medicine shortages that vex pharmacists, exasperate patients and risk overloading public health services.
"There are often several dozen medications that are in short supply simultaneously, which makes our lives very difficult," said Didier Ronsyn, a Brussels pharmacist.
An EU audit last month found shortages were a "chronic headache" across the bloc.
Its 27 states reported running critically short of 136 drugs, including antibiotics and medicines used to treat heart attacks, between 2022 and 2024, the European Court of Auditors (ECA) said.
Belgium reported the most cases, with more than a dozen critical instances -- meaning no alternatives are available -- notified to the European Medicines Agency (EMA) in 2024 only.
The cause partially lies in supply chain snags and Europe's over-reliance on Asia for key drug components, the ECA said.
Cheaper prices mean that Asian producers now supply the EU with 70 percent of the active pharmaceutical ingredients it needs, according to a study cited in the ECA report.
The dependency is particularly acute for painkillers, like paracetamol or ibuprofen, and drugs that ran critically low in recent years, including some antibiotics and salbutamol, an asthma drug sold under the brand name Ventolin.
Yet, EU internal market inefficiencies are also to blame.
- 'Colossal workload' -
Drug prices differ within the bloc as national authorities negotiate individually with producers, explained Olivier Delaere, CEO of Febelco, a wholesale distributor that serves about 40 percent of Belgian pharmacies.
As a consequence, manufacturers tend to deliver more to countries that pay more, and just enough to those who drove a harder bargain -- to avoid drugs being re-exported for profit, he said.
Additionally, the ECA said that most medicines are still authorised at national level and packages differ significantly among countries, which makes internal EU trade "more costly and complex".
This causes so-called "local shortages", when a product is not available in one EU country but can be found just across the border in another member state, said Delaere of Febelco.
"It's a growing problem," he said, as a massive automated dispenser stacked with medicine boxes filled green baskets -- each corresponding to a pharmacist's order -- on a conveyor belt in the warehouse behind him.
Some 70 percent of the about one million client calls the firm receives a year "are focused solely on medicine shortages", Delaere said. "It is an absolutely colossal workload and energy drain."
- 'Complicated', for now -
In 2024, EU pharmacists spent on average 11 hours per week managing shortages, according to PGEU, a pharmacists' trade group.
Ronsyn said he often spends an hour a day "making phone calls, checking information, sending patients away, or calling them back to tell them their medication has arrived or in certain cases, that it hasn't" -- something that did not happen in the past.
"It's also tough for the patient, who might panic a little when they don't get their medication on time," he said.
Brussels has been scrambling to find solutions.
In March, the European Commission proposed a "critical medicines act" aimed at boosting manufacturing in the EU by providing incentives and urging member states to move away from price as the key criterion for awarding procurement contracts.
It was followed in July by a "stockpiling strategy" to coordinate stocks and ensure medicines and other goods are available in case of crisis.
A commission spokeswoman said Brussels was confident that these and other recently introduced proposals "will make a substantial difference" and "significantly help tackling the problem".
The bills are currently being negotiated with the European Parliament and member states, a sometimes lengthy process.
"They are trying to find solutions, but it is always very slow," said Ronsyn, whose pharmacy overlooks the commission offices. "We will probably get there someday, but for now it's complicated."
N.Walker--AT